Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
74 words
A process for inserting foreign DNA I into a suitable eucaryotic cell which comprises cotransforming said eucaryotic cell with said foreign DNA I and with unlinked foreign DNA II which codes for a selectable phenotype not expressed by said eucaryotic cell, said cotransformation being carried out under suitable conditions permitting survival or identification of eucaryotic cells which have acquired said selectable phenotype, said foreign DNA II being attached to bacterial plasmid or phage DNA.
Claim 2
Dependent Claim
74 words
A process for inserting foreign DNA I into a suitable eucaryotic cell which comprises cotransforming said eucaryotic cell with said foreign DNA I and with unlinked foreign DNA II which codes for a selectable phenotype not expressed by said eucaryotic cell, said cotransformation being carried out under suitable conditions permitting survival or identification of eucaryotic cells which have acquired said selectable phenotype, said foreign DNA II being attached to bacterial plasmid or phage DNA.
Claim 3
Dependent Claim
25 words
A process in accordance with claim 1, wherein the DNA I or KNA II is attached to phage DNA and encapsidated in a phage particle.
Claim 4
Dependent Claim
20 words
A process in accordance with claim 1, wherein the DNA I or DNA II is attached to bacterial plasmid DNA.
Claim 5
Dependent Claim
16 words
A process in accordance with claim 3, wherein the bacterial plasmid DNA is derived from pBR322.
Claim 6
Dependent Claim
24 words
A process in accordance with claim 1, wherein said foreign DNA I codes for proteinaceous material which is not associated with a selectable phenotype.
Claim 7
Dependent Claim
35 words
A process in accordance wirh claim 5, wherein the proteinaceous material which is not associated with a selectable phenotype comprises interferon protein, insulin, a growth hormone, a clotting factor, a viral antigen or an antibody.
Claim 8
Dependent Claim
37 words
A process in accordance with claim 1, wherein said foreign DNA I is present in an amount relative to said DNA II which codes for a selectable phenotype in the range from about 1:1 to about 1000,000:1.
Claim 9
Dependent Claim
27 words
A process in accordance with claim 1, wherein said DNA II which codes for a selectable phenotype comprises the gene for thymidine kinase from herpes simplex virus.
Claim 10
Dependent Claim
23 words
A process in accordance with claim 1, wherein said DNA II which codes for a selectable phenotype comprises the gene for adenine phosphoribousyltransferase.
Claim 11
Dependent Claim
24 words
A process in accordance with claim 1, wherein said DNA II which codes for a selectable phenotype comprises a gene associated with drug resistance.
Claim 12
Dependent Claim
29 words
A process in accordance with claim 10, wherein the gene associated with drug resistance is the gene coding for a mutant dihydrofolate reductase which renders cells resistant to methotrexate.
Claim 13
Dependent Claim
19 words
A eucaryotic cell into which foreign DNA I has been inserted in accordance with the process of claim 1.
Claim 14
Dependent Claim
19 words
A mammalian cell into which foreign DNA I has been inserted in accordance with the process of claim 1.
Claim 15
Dependent Claim
43 words
A process for producing a proteinaceous material which comprises cotransforming a suitable eucaryotic cell in accordance with the process of claim 1, maintaining the cotransformed eucaryotic cell under suitable conditions permitting production of the proteinaceous material and recovering the proteinaceous material so produced.
Claim 16
Dependent Claim
16 words
A process in accordance with claim 14, wherein the suitable eucaryotic cell is a mammalian cell.
Claim 17
Dependent Claim
93 words
A process for producing a proteinaceous material which comprises cotransforming a suitable eucaryotic cell with foreign DNA I which codes for foreign proteinaceous material which is not associated with a selectable phenotype and with unlinked foreign DNA II which codes for a selectable phenotype not expressed by the eucaryotic cell, said cotransformation being carried out under suitable conditions permitting survival or identification of eucaryotic cells which have acquired the selectable phenotype, maintaining or culturing the cotransformed cells under suitable conditions permitting production of the proteinaceous material and recovering the proteinaceous material so produced.
Claim 18
Dependent Claim
93 words
A process for producing a proteinaceous material which comprises cotransforming a suitable eucaryotic cell with foreign DNA I which codes for foreign proteinaceous material which is not associated with a selectable phenotype and with unlinked foreign DNA II which codes for a selectable phenotype not expressed by the eucaryotic cell, said cotransformation being carried out under suitable conditions permitting survival or identification of eucaryotic cells which have acquired the selectable phenotype, maintaining or culturing the cotransformed cells under suitable conditions permitting production of the proteinaceous material and recovering the proteinaceous material so produced.
Claim 19
Dependent Claim
15 words
A process in accordance with claim 16, wherein the eucaryotic cell is a mammaliam cell.
Claim 20
Dependent Claim
30 words
A process in accordance with claim 16, wherein the foreign DNA I is present in an amount relative to DNA II in the range from about 1:1 to about 100,000:1.
Claim 21
Dependent Claim
27 words
A process in accordance with claim 16, wherein the DNA II which codes for a selectable phenotype comprises the gene for thymidine kinase from herpes simplex virus.
Claim 22
Dependent Claim
23 words
A process in accordance with claim 16, wherein the DNA II which codes for a selectable phenotype comprises the gene for adenine phosphoribosyltransferase.
Claim 23
Dependent Claim
24 words
A process in accordance with claim 16, wherein the DNA II which codes for a selectable phenotype comprises a gene associated with drug resistance.
Claim 24
Dependent Claim
29 words
A process in accordance with claim 21, wherein the gene associated with drug resistance is the gene coding for a mutant dihydrofolate reductase which renders cells resistant to methotrexate.
Claim 25
Dependent Claim
21 words
A process in accordance with claim 16, wherein the eucaryotic cell is cotransformed with a multiplicity of foreign DNA I molecules.